Federated Hermes
CLPT icon

Federated Hermes’s ClearPoint Neuro CLPT Stock Holding History

Federated Hermes’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.48K Sell
307
-63
-17% -$787 ﹤0.01% 1905
2026
Q1 		$3.37K Sell
370
-14
-4% -$177 ﹤0.01% 1932
2025
Q4 		$5.25K Sell
384
-90
-19% -$1.67K ﹤0.01% 1887
2025
Q3 		$10.3K Sell
474
-21
-4% -$247 ﹤0.01% 1873
2025
Q2 		$5.91K Buy
+495
New +$6.23K ﹤0.01% 1876
2021
Q2 		– Sell
-330
Closed -$7K – 2223
2021
Q1 		$7K Buy
330
+22
+7% +$471 ﹤0.01% 2034
2020
Q4 		$5K Buy
+308
New +$2.76K ﹤0.01% 2043

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Federated Hermes's CLPT Position: Q2 2026 in Review

Federated Hermes reduced its ClearPoint Neuro (CLPT) stake by 17% in Q2 2026, selling an estimated $787 and leaving 307 shares worth $5.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1905.

Federated Hermes first reported a position in CLPT in Q4 2020 and has held it in 7 quarters since. The position peaked at $10.3K in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Federated Hermes held 307 shares of ClearPoint Neuro worth $5.48K as of Q2 2026.
  • Federated Hermes sold 63 ClearPoint Neuro shares in Q2 2026, an estimated $787.
  • ClearPoint Neuro made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1905 holding.
  • Federated Hermes first reported a position in ClearPoint Neuro in Q4 2020 and has held it in 7 quarters since.
  • Federated Hermes's ClearPoint Neuro position peaked at $10.3K in Q3 2025.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.